Cardiometabolic healthcare for men with prostate cancer: an MD Anderson Cancer Center experience

Abstract Background Men diagnosed with prostate cancer are at risk for competing morbidity and mortality due to cardiometabolic disease given their advanced age at diagnosis, high prevalence of pre-existing risk factors, and receipt of systemic therapy that targets the androgen receptor (AR). Expert...

Full description

Bibliographic Details
Main Authors: Andrew W. Hahn, Whittney Thoman, Efstratios Koutroumpakis, Amer Abdulla, Sumit K. Subudhi, Ana Aparicio, Karen Basen-Enngquist, Christopher J. Logothetis, Susan C. Gilchrist
Format: Article
Language:English
Published: BMC 2023-09-01
Series:Cardio-Oncology
Subjects:
Online Access:https://doi.org/10.1186/s40959-023-00186-x